Literature DB >> 9875115

Selection of the optimal stress test for the diagnosis of coronary artery disease.

J A San Román1, I Vilacosta, J A Castillo, M J Rollán, M Hernández, V Peral, I Garcimartín, M M de la Torre, F Fernández-Avilés.   

Abstract

OBJECTIVE: To compare the value and limitations of exercise testing, dipyridamole echocardiography, dobutamine-atropine echocardiography, and MIBI-SPECT (technetium-99m methoxyisobutyl nitrile single photon emission computed tomography) during dobutamine infusion in the diagnosis of coronary artery disease.
DESIGN: The performance of these four tests was assessed in random order on a consecutive cohort of patients. The presence or absence of coronary artery disease was confirmed by coronary angiography.
SETTING: Two tertiary care and university centres. PATIENTS: 102 consecutive patients with chest pain and no previous history of coronary artery disease. Ten patients with left bundle branch block were excluded for further analysis of exercise testing and scintigraphy results.
RESULTS: MIBI-SPECT was the most sensitive (87%) but the least specific test (70%). Exercise stress testing had a sensitivity of 66%, which increased to 80% when patients with inconclusive results were excluded. Dipyridamole and dobutamine echocardiography had similar sensitivity (81%, 78%) and specificity (94%, 88%). All four tests had similar accuracy and positive and negative predictive values. Agreement between the echocardiographic techniques was excellent (detection of coronary artery disease 87%, kappa = 0.72; regional analysis 93%, kappa = 0.72; diagnosis of the "culprit" vessel 95%, kappa = 0.92), and it was good between echocardiographic techniques and MIBI-SPECT (diagnosis of the culprit vessel 90%, kappa = 0.84 with dobutamine and 92%, kappa = 0.85 with dipyridamole).
CONCLUSIONS: Exercise stress testing has a sensitivity comparable to other tests in patients capable of exercising and with no basal electrical abnormalities. The greatest sensitivity is offered by MIBI-SPECT and the greatest specificity is obtained with stress echocardiography. Redundant information is obtained with dipyridamole echocardiography, dobutamine echocardiography, and MIBI-SPECT.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875115      PMCID: PMC1728805          DOI: 10.1136/hrt.80.4.370

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  39 in total

1.  Dobutamine stress echocardiography: its role in the diagnosis of coronary artery disease.

Authors:  A Salustri; P M Fioretti; M M Pozzoli; A J McNeill; J R Roelandt
Journal:  Eur Heart J       Date:  1992-01       Impact factor: 29.983

2.  Dobutamine stress echocardiography for detection and assessment of coronary artery disease.

Authors:  P K Mazeika; A Nadazdin; C M Oakley
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

3.  Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease.

Authors:  T Forster; A J McNeill; A Salustri; A E Reijs; E S el-Said; J R Roelandt; P M Fioretti
Journal:  J Am Coll Cardiol       Date:  1993-06       Impact factor: 24.094

4.  Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease.

Authors:  M Previtali; L Lanzarini; R Fetiveau; A Poli; M Ferrario; C Falcone; A Mussini
Journal:  Am J Cardiol       Date:  1993-10-15       Impact factor: 2.778

5.  Comparative evaluation of bicycle and dobutamine stress echocardiography with perfusion scintigraphy and bicycle electrocardiogram for identification of coronary artery disease.

Authors:  R Hoffmann; H Lethen; E Kleinhans; M Weiss; F A Flachskampf; P Hanrath
Journal:  Am J Cardiol       Date:  1993-09-01       Impact factor: 2.778

6.  Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.

Authors:  H Mertes; S G Sawada; T Ryan; D S Segar; R Kovacs; J Foltz; H Feigenbaum
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

7.  Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischaemia: a comparison between dobutamine and dipyridamole.

Authors:  A Salustri; P M Fioretti; A J McNeill; M M Pozzoli; J R Roelandt
Journal:  Eur Heart J       Date:  1992-10       Impact factor: 29.983

8.  Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography.

Authors:  T Marwick; B Willemart; A M D'Hondt; T Baudhuin; W Wijns; J M Detry; J Melin
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

9.  Value of dobutamine technetium-99m-sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography.

Authors:  B Günalp; B Dokumaci; C Uyan; E Vardareli; E Işik; H Bayhan; M Ozgüven; E Oztürk
Journal:  J Nucl Med       Date:  1993-06       Impact factor: 10.057

10.  Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both?

Authors:  T Marwick; A M D'Hondt; T Baudhuin; B Willemart; W Wijns; J M Detry; J Melin
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

View more
  17 in total

1.  Head-to-head comparison of dipyridamole echocardiography and stress perfusion scintigraphy for the detection of coronary artery disease: a meta-analysis. Comparison between stress echo and scintigraphy.

Authors:  Muhammad B Imran; Attila Pálinkás; Eugenio Picano
Journal:  Int J Cardiovasc Imaging       Date:  2003-02       Impact factor: 2.357

Review 2.  Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging.

Authors:  C Y Loong; C Anagnostopoulos
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

3.  Coronary flow reserve by CT perfusion.

Authors:  Richard T George; Frank M Bengel; Albert C Lardo
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 4.  Quantitative and qualitative analysis and interpretation of CT perfusion imaging.

Authors:  Carolina Valdiviezo; Marietta Ambrose; Vishal Mehra; Albert C Lardo; Joao A C Lima; Richard T George
Journal:  J Nucl Cardiol       Date:  2010-12       Impact factor: 5.952

5.  A meta-analytic comparison of echocardiographic stressors.

Authors:  Yoshinori Noguchi; Shizuko Nagata-Kobayashi; James E Stahl; John B Wong
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

6.  Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease: a summary of evidence-based analyses.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01

7.  Myocardial CT perfusion imaging and SPECT for the diagnosis of coronary artery disease: a head-to-head comparison from the CORE320 multicenter diagnostic performance study.

Authors:  Richard T George; Vishal C Mehra; Marcus Y Chen; Kakuya Kitagawa; Armin Arbab-Zadeh; Julie M Miller; Matthew B Matheson; Andrea L Vavere; Klaus F Kofoed; Carlos E Rochitte; Marc Dewey; Tan S Yaw; Hiroyuki Niinuma; Winfried Brenner; Christopher Cox; Melvin E Clouse; João A C Lima; Marcelo Di Carli
Journal:  Radiology       Date:  2014-05-26       Impact factor: 11.105

8.  Stress echocardiography for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01

9.  Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01

10.  Noninvasive detection of the hemodynamic stress of exercise using the photoplethysmogram.

Authors:  Stephen Paul Linder; Suzanne Wendelken; Jeffrey Clayman; Paul R Steiner
Journal:  J Clin Monit Comput       Date:  2008-06-25       Impact factor: 2.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.